Delivery Order SPE2DB24D3015-SPE2DB25FFXQU

Award Date 1/10/25
Potential Completion Date 1/13/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,554.64 firm fixed price delivery order is for the supply of 4,564,702,627 units of the medication Tamsulosin HCl 0.4 mg capsules. The contract has an ultimate completion date of May 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a $11,708.76 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4565020557 - TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, with a performance period through June 28, 2024. Amerisourcebergen has established itself as a key vendor for federal healthcare programs, particularly within military and veterans'...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,326.16 firm-fixed-price delivery order is for the supply of 4,566,280,778 units of Tamsulosin HCL 0.4 mg capsules, with a completion date of October 31, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,843.85 fixed-price contract is for the delivery of 1,000 units of the prescription medication Tamsulosin HCL 0.4 mg capsules, with a completion date of December 2, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S. The order has a ceiling value of $1,171.36 and a completion date of March 8, 2024. The contract is a Firm Fixed Price arrangement. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,530.81 firm fixed-price delivery order is for the supply of 4,562,264,266 Tamsulosin HCl 0.4 mg capsules. The contract has an ultimate completion date of September 22, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a firm fixed price of $2,033.85 and a completion date of January 10, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,715.49 firm fixed-price contract is for the delivery of 4,564,465,528 units of Tamsulosin HCl 0.4 mg capsules. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,824.30, is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, with a completion date of February 2, 2024. This is a firm fixed price Delivery Order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,778.86 Firm Fixed Price contract is for the supply of 4,567,152,479 units of Tamsulosin HCL 0.4 mg capsules. The contract has a completion date of February 5, 2025 and was awarded on February 4, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB25FFXQU
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,478.23 firm fixed-price delivery order is for TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, with a period of performance through January 13, 2025.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order falls under that broader IDC. The contract does not have a set-aside designation, indicating open competition.

Generated 4/11/25, 11:20 AM